Effects of diet and antihyperglycemic drugs on erectile dysfunction: A systematic review.


Journal

Andrology
ISSN: 2047-2927
Titre abrégé: Andrology
Pays: England
ID NLM: 101585129

Informations de publication

Date de publication:
02 2023
Historique:
revised: 27 03 2022
received: 20 03 2022
accepted: 31 03 2022
pubmed: 30 4 2022
medline: 18 1 2023
entrez: 29 4 2022
Statut: ppublish

Résumé

Erectile dysfunction is recognized as one of the complications of diabetes mellitus. To date, a wide gap of knowledge is present on the efficacy of pharmacological treatments of diabetes mellitus on erectile function, acting not only through metabolic control. Similarly, the effects of different diet regimens on erectile dysfunction are still debated. We aimed to explore the effects of diet and antihyperglycemic drugs, considering both old and novel therapeutic approaches, on erectile function. We performed a systematic review, following the PRISMA guidelines. The research was conducted on studies reporting erectile dysfunction assessment in subjects with diabetes and the relationship with diet and antihyperglycemic drugs. The Mediterranean diet was effective in most studies for the protection of erectile function. Furthermore, antihyperglycemic drugs seem to show an overall protective role on erectile function. Although encouraging results are present for all classes of antihyperglycemic drugs, several studies are needed in humans, mainly on acarbose, pioglitazone, dipeptidyl-peptidase-4 inhibitors, and sodium-glucose cotransporter-2 inhibitors.

Sections du résumé

BACKGROUND
Erectile dysfunction is recognized as one of the complications of diabetes mellitus. To date, a wide gap of knowledge is present on the efficacy of pharmacological treatments of diabetes mellitus on erectile function, acting not only through metabolic control. Similarly, the effects of different diet regimens on erectile dysfunction are still debated.
OBJECTIVES
We aimed to explore the effects of diet and antihyperglycemic drugs, considering both old and novel therapeutic approaches, on erectile function.
MATERIALS/METHODS
We performed a systematic review, following the PRISMA guidelines. The research was conducted on studies reporting erectile dysfunction assessment in subjects with diabetes and the relationship with diet and antihyperglycemic drugs.
RESULTS
The Mediterranean diet was effective in most studies for the protection of erectile function. Furthermore, antihyperglycemic drugs seem to show an overall protective role on erectile function.
DISCUSSION/CONCLUSION
Although encouraging results are present for all classes of antihyperglycemic drugs, several studies are needed in humans, mainly on acarbose, pioglitazone, dipeptidyl-peptidase-4 inhibitors, and sodium-glucose cotransporter-2 inhibitors.

Identifiants

pubmed: 35485604
doi: 10.1111/andr.13192
pmc: PMC10084359
doi:

Substances chimiques

Hypoglycemic Agents 0
Sodium-Glucose Transporter 2 Inhibitors 0

Types de publication

Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

282-294

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2022 American Society of Andrology and European Academy of Andrology.

Références

J Clin Med. 2021 Jun 05;10(11):
pubmed: 34198786
Lancet. 2019 Jul 13;394(10193):121-130
pubmed: 31189511
Expert Opin Pharmacother. 2021 Feb;22(2):179-189
pubmed: 32902360
JAMA Netw Open. 2020 Nov 2;3(11):e2021701
pubmed: 33185675
JAMA. 2004 Jun 23;291(24):2978-84
pubmed: 15213209
Basic Clin Androl. 2021 May 13;31(1):11
pubmed: 33980148
J Food Biochem. 2021 Mar;45(3):e13323
pubmed: 32538504
Urology. 2014 Nov;84(5):1122-7
pubmed: 25443915
Intern Med J. 2016 Jan;46(1):52-6
pubmed: 26482327
J Sex Med. 2020 Jul;17(7):1280-1287
pubmed: 32624131
J Sex Med. 2014 Aug;11(8):2065-73
pubmed: 25041930
BJU Int. 2007 Oct;100(4):867-74
pubmed: 17662078
Int J Clin Pract Suppl. 2007 Aug;(154):12-8
pubmed: 17593273
Med Hypotheses. 2016 Apr;89:96
pubmed: 26968918
Rev Endocr Metab Disord. 2015 Oct 26;:
pubmed: 26497842
Urology. 2004 Apr;63(4):800-5
pubmed: 15072915
J Am Heart Assoc. 2018 Jun 28;7(13):
pubmed: 29954747
Obes Res Clin Pract. 2013 Dec;7(6):e450-4
pubmed: 24459689
Lancet Diabetes Endocrinol. 2021 Aug;9(8):472-473
pubmed: 34153270
J Diabetes Sci Technol. 2018 Nov;12(6):1252-1253
pubmed: 30156866
J Androl. 2012 Jul-Aug;33(4):608-14
pubmed: 22016348
J Sex Med. 2012 Jul;9(7):1801-14
pubmed: 22524530
Diabetes Metab Res Rev. 2022 Feb;38(2):e3494
pubmed: 34514697
Int J Impot Res. 2020 Dec;33(8):844-853
pubmed: 33009496
Diabetes Care. 2003 May;26(5):1589-96
pubmed: 12716823
Int J Impot Res. 2017 Jan;29(1):17-22
pubmed: 27654032
Int J Immunopathol Pharmacol. 2019 Jan-Dec;33:2058738419866582
pubmed: 32031031
J Physiol. 2016 Jun 1;594(11):3045-60
pubmed: 26840628
Front Pharmacol. 2020 Aug 12;11:1257
pubmed: 32903510
Andrology. 2017 Sep;5(5):1023-1031
pubmed: 28743168
Arch Ital Urol Androl. 2018 Mar 31;90(1):44-48
pubmed: 29633797
J Diabetes Complications. 2016 Nov - Dec;30(8):1519-1524
pubmed: 27614727
JAMA. 2019 May 21;321(19):1926-1927
pubmed: 31009043
Diabetes Care. 2020 Jan;43(Suppl 1):S98-S110
pubmed: 31862752
Diabetes. 2001 Jun;50(6):1290-301
pubmed: 11375329
J Sex Med. 2019 Jun;16(6):791-802
pubmed: 31010783
Urol Clin North Am. 2005 Nov;32(4):379-95, v
pubmed: 16291031
J Sex Med. 2013 Sep;10(9):2154-64
pubmed: 23889981
Int J Impot Res. 2006 Jul-Aug;18(4):405-10
pubmed: 16395320
Lancet Diabetes Endocrinol. 2021 Aug;9(8):484-490
pubmed: 34153269
Int J Impot Res. 2006 Jul-Aug;18(4):370-4
pubmed: 16395326
J Sex Med. 2010 Jan;7(1 Pt 1):156-65
pubmed: 19694925
Diabetes Care. 2015 Jan;38(1):140-9
pubmed: 25538310
Diabetologia. 2018 Oct;61(10):2108-2117
pubmed: 30132036
Med Hypotheses. 2015 Aug;85(2):124-6
pubmed: 25913811
J Clin Endocrinol Metab. 2019 Mar 1;104(3):819-822
pubmed: 30395251
J Korean Med Sci. 2016 Apr;31(4):585-9
pubmed: 27051243
Urology. 2020 Oct;144:147-151
pubmed: 32717247
J Urol. 2011 May;185(5):1828-34
pubmed: 21420129
J Coll Physicians Surg Pak. 2011 Sep;21(9):517-21
pubmed: 21914405
Atherosclerosis. 2009 Jun;204(2):544-8
pubmed: 19013573
Hematol Oncol Clin North Am. 1998 Jun;12(3):631-48
pubmed: 9684102
Curr Med Chem. 2018;25(9):1002-1035
pubmed: 29110598
Am J Clin Nutr. 2016 Feb;103(2):534-41
pubmed: 26762373
BMJ. 2017 Jun 8;357:j2499
pubmed: 28596247
Urology. 2013 Dec;82(6):1330-5
pubmed: 24295250
J Clin Diagn Res. 2016 Dec;10(12):FC21-FC26
pubmed: 28208875
J Sex Med. 2012 Sep;9(9):2273-83
pubmed: 22429455
Am J Med. 2021 Mar;134(3):310-316
pubmed: 33227246
PLoS One. 2016 Sep 01;11(9):e0161297
pubmed: 27584019
Med Hypotheses. 2014 Apr;82(4):504
pubmed: 24529641
Urology. 2022 Mar;161:76-82
pubmed: 34979217
J Androl. 2007 Jul-Aug;28(4):555-60
pubmed: 17314235
J Sex Med. 2018 Sep;15(9):1224-1234
pubmed: 30145094
Bioanalysis. 2019 Jul;11(14):1321-1336
pubmed: 31368774
Diabetologia. 2001 May;44(5):593-601
pubmed: 11380077
Andrologia. 2021 Jun;53(5):e14038
pubmed: 33694187
Nutrients. 2020 Dec 30;13(1):
pubmed: 33396861
J Clin Diagn Res. 2015 Jan;9(1):BC04-7
pubmed: 25737972
BMJ Open. 2016 Aug 31;6(8):e010863
pubmed: 27580828
Rev Endocr Metab Disord. 2020 Mar;21(1):57-65
pubmed: 31863254
J Pharm Pharm Sci. 2008;11(1):22-31
pubmed: 18445362
Andrology. 2023 Feb;11(2):282-294
pubmed: 35485604
J Sex Med. 2010 May;7(5):1911-7
pubmed: 20214716
Int J Impot Res. 2021 Jul;33(5):548-555
pubmed: 32488209
J Sex Med. 2018 Feb;15(2):176-182
pubmed: 29325831
CMAJ. 2020 Oct 19;192(42):E1271
pubmed: 33077524
J Urol. 2002 Jul;168(1):355-61
pubmed: 12050569
Andrology. 2018 Sep;6(5):665-679
pubmed: 29888533
Zhonghua Nan Ke Xue. 2016 Mar;22(3):212-8
pubmed: 27172659
Urology. 2015 Aug;86(2):423.e1-6
pubmed: 26199165
Transl Androl Urol. 2017 Jun;6(3):556-565
pubmed: 28725599
J Huazhong Univ Sci Technolog Med Sci. 2017 Aug;37(4):523-530
pubmed: 28786059
Andrologia. 2019 Jun;51(5):e13264
pubmed: 30873650
Front Physiol. 2017 Oct 04;8:760
pubmed: 29085300
Andrology. 2015 Nov;3(6):1094-103
pubmed: 26447645
Diabetes Technol Ther. 2009 Aug;11(8):517-21
pubmed: 19698065
Curr Vasc Pharmacol. 2018 Jan 26;16(2):130-142
pubmed: 28595561
Fertil Steril. 2007 Oct;88(4):771-8
pubmed: 17498710
Int J Obes (Lond). 2010 Sep;34(9):1396-403
pubmed: 20404829
J Cell Mol Med. 2015 May;19(5):960-9
pubmed: 25781208
Hormones (Athens). 2018 Mar;17(1):113-117
pubmed: 29858857
J Sex Med. 2010 Apr;7(4 Pt 2):1598-607
pubmed: 20388160
J Sex Med. 2011 Oct;8(10):2868-75
pubmed: 21819545
Am J Hypertens. 2019 Nov 15;32(12):1206-1213
pubmed: 31584631
Urol J. 2015 Apr 29;12(2):2099-102
pubmed: 25923156
Peptides. 2018 Aug;106:1-8
pubmed: 29792899
Eur Urol. 2014 Jan;65(1):99-112
pubmed: 24050791
Curr Top Med Chem. 2020;20(1):37-56
pubmed: 31884929
Fertil Steril. 1996 Jan;65(1):68-75
pubmed: 8557157
Medicine (Baltimore). 2016 Jan;95(4):e2557
pubmed: 26825896
World J Mens Health. 2019 May;37(2):138-147
pubmed: 30079640
Vasc Health Risk Manag. 2013;9:429-33
pubmed: 24023518
Int J Impot Res. 2019 Jan;31(1):1-8
pubmed: 30072768
Hypertension. 2000 Jan;35(1 Pt 1):108-12
pubmed: 10642283
Urologia. 2017 Oct 25;84(4):221-225
pubmed: 28731489
BJU Int. 2006 Jul;98(1):116-24
pubmed: 16831155
Urology. 2016 Mar;89:76-82
pubmed: 26772642
J Urol. 2002 Nov;168(5):2296-300
pubmed: 12394778
Int J Biol Sci. 2021 May 11;17(8):2050-2068
pubmed: 34131405
Int J Androl. 2011 Oct;34(5 Pt 2):e468-74
pubmed: 21790657
Endocrinology. 2015 Apr;156(4):1372-85
pubmed: 25590244
Arterioscler Thromb Vasc Biol. 2020 Mar;40(3):506-522
pubmed: 31996025

Auteurs

Giuseppe Defeudis (G)

Unit of Endocrinology and Diabetes, Department of Medicine, University Campus Bio-Medico di Roma, Rome, Italy.

Rossella Mazzilli (R)

Unit of Endocrinology, Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy.

Alfonso Maria Di Tommaso (AM)

Unit of Endocrinology and Diabetes, Department of Medicine, University Campus Bio-Medico di Roma, Rome, Italy.

Virginia Zamponi (V)

Unit of Endocrinology, Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy.

Francesco Carlomagno (F)

Department of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, Rome, Italy.

Dario Tuccinardi (D)

Unit of Endocrinology and Diabetes, Department of Medicine, University Campus Bio-Medico di Roma, Rome, Italy.

Mikiko Watanabe (M)

Department of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, Rome, Italy.

Antongiulio Faggiano (A)

Unit of Endocrinology, Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy.

Daniele Gianfrilli (D)

Department of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH